TABLE 2.
ALKBH5 | ||||
---|---|---|---|---|
All cases | Low expression | High expression | p‐Value | |
Gender | ||||
Female | 47 | 26 | 21 | .341 |
Male | 67 | 43 | 24 | |
Age | ||||
≤60 | 41 | 30 | 11 | .038* |
> 60 | 73 | 39 | 34 | |
Tumour size | ||||
≤5 | 77 | 47 | 30 | .872 |
> 5 | 37 | 22 | 15 | |
Histological type | ||||
Adenocarcinoma | 112 | 67 | 45 | .249 |
Others | 2 | 2 | 0 | |
Tumour differentiation | ||||
Well and moderate | 93 | 58 | 35 | .398 |
Poor | 21 | 11 | 10 | |
Lymphovascular invasion | ||||
Positive | 53 | 30 | 23 | .424 |
Negative | 61 | 39 | 22 | |
T stage | ||||
T1 + T2 | 19 | 9 | 10 | .199 |
T3 + T4 | 95 | 60 | 35 | |
N stage | ||||
N0 | 62 | 33 | 29 | .082 |
N1 + N2 | 52 | 36 | 16 | |
M stage | ||||
M0 | 92 | 51 | 41 | .042* |
M1 | 22 | 18 | 4 | |
AJCC stage | ||||
I + II | 56 | 28 | 28 | .024* |
III + IV | 58 | 41 | 17 |
p‐Value <.05.